Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes

Overview of attention for article published in New England Journal of Medicine, September 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 3 Google+ posts from 3 users.

Cardiovascular disease is the leading cause of death and complications in patients with type 2 diabetes... Cardiovascular…

In patients with type 2 diabetes who were at high cardiovascular risk, the rate of cardiovascular death... In patients with…

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes — NEJM Original Article from The New England Journal…

This page shows the most recent Google+ posts that mention this research output.

Click here to find out how to access more activity.